Genix Pharmaceuticals Receivables

The latest receivables for GENPF is $2.6K as of April 2026. That compares with $2.8K in the prior-year period — down 4.5% year over year. Investors often review this figure alongside Genix Pharmaceuticals's historical trend and sector peers before judging valuation or financial health.

Over the past year, GENPF's receivables moved from $2.8K to $2.6K — a 4.5% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Genix Pharmaceuticals's operating scale or balance-sheet position.

A receivables figure of $2.6K for GENPF is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting GENPF's receivables ($2.6K), review year-over-year change from $2.8K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.